Axel Hauschild
Overview
Explore the profile of Axel Hauschild including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
327
Citations
22732
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saiag P, Lebbe C, Brochez L, Emile J, Forsea A, Harwood C, et al.
Eur J Cancer
. 2025 Feb;
218:115265.
PMID: 39904126
Dermatofibrosarcoma protuberans (DFSP) is a cutaneous fibroblastic tumour that is locally aggressive, with a tendency for local recurrence, but rarely metastasizes. A collaboration of multi-disciplinary experts from the European Association...
2.
Mo J, Zaremba A, Inderjeeth A, El Zeinaty P, Li A, Wicky A, et al.
Eur J Cancer
. 2025 Jan;
217:115254.
PMID: 39874912
Aim: Merkel Cell Carcinoma (MCC) is a rare skin cancer with a rising incidence worldwide. Anti-programmed death-1/ligand-1 (anti-PD-(L)1) therapies are effective for the treatment of advanced MCC. This study examines...
3.
Haggenmuller S, Wies C, Abels J, Winterstein J, Heinlein L, Nogueira Garcia C, et al.
Nat Commun
. 2025 Jan;
16(1):789.
PMID: 39824857
Accurate melanoma diagnosis is crucial for patient outcomes and reliability of AI diagnostic tools. We assess interrater variability among eight expert pathologists reviewing histopathological images and clinical metadata of 792...
4.
Hauschild A, Garbe C, Ascierto P, Demidov L, Dreno B, Dummer R, et al.
Lancet Oncol
. 2025 Jan;
26(1):12-14.
PMID: 39756440
No abstract available.
5.
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al.
Eur J Cancer
. 2024 Dec;
215:115153.
PMID: 39709737
A unique collaboration of multi-disciplinary experts from the European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF), and the European Organization of Research and Treatment of Cancer (EORTC) was...
6.
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2024
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al.
Eur J Cancer
. 2024 Dec;
215:115152.
PMID: 39700658
This guideline was developed in close collaboration with multidisciplinary experts from the European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF) and the European Organization for Research and Treatment...
7.
Lang B, Balermpas P, Bauer A, Blum A, Dirschka T, Follmann M, et al.
J Dtsch Dermatol Ges
. 2024 Nov;
22(12):1697-1714.
PMID: 39584658
Basal cell carcinoma is the most common malignant tumor in the fair-skinned population and its incidence continues to rise. An update of the S2k guideline with the participation of all...
8.
Gutzmer R, Leiter U, Mohr P, Kahler K, Ascierto P, Scalvenzi M, et al.
BMC Cancer
. 2024 Nov;
24(1):1401.
PMID: 39538176
Background: Following the pivotal phase II trial BOLT, the Hedgehog (Hh) inhibitor sonidegib was approved in the EU to treat locally advanced basal cell carcinoma (laBCC) in patients not amenable...
9.
Heinlein L, Maron R, Hekler A, Haggenmuller S, Wies C, Utikal J, et al.
Commun Med (Lond)
. 2024 Sep;
4(1):177.
PMID: 39256516
Background: Early detection of melanoma, a potentially lethal type of skin cancer with high prevalence worldwide, improves patient prognosis. In retrospective studies, artificial intelligence (AI) has proven to be helpful...
10.
Hughes B, Guminski A, Bowyer S, Migden M, Schmults C, Khushalani N, et al.
J Am Acad Dermatol
. 2024 Sep;
92(1):68-77.
PMID: 39245360
Background: In the phase 2 EMPOWER-CSCC-1 study (NCT02760498), cemiplimab demonstrated antitumor activity against metastatic cutaneous squamous cell carcinoma (mCSCC) and locally advanced cutaneous squamous cell carcinoma (laCSCC). Objectives: To report...